Bicycle Therapeutics plc
BCYCNasdaqCIK 1761612HealthcareFiscal year ends Dec 31
All transactions: 10
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2020-07-15 | Glaxosmithkline plc10% owner | Sale | 78 | $19.25 | $1.5k | Form 4 |
| 2020-07-15 | Glaxosmithkline plc10% owner | Sale | 3,069 | $19.4016 | $59.5k | Form 4 |
| 2020-07-14 | Glaxosmithkline plc10% owner | Sale | 1,597 | $19.274 | $30.8k | Form 4 |
| 2019-05-28 | Glaxosmithkline plcDirector, 10% owner | Purchase | 385,714 | $14.00 | $5.4m | Form 4 |
| 2019-05-28 | Glaxosmithkline plcDirector, 10% owner | Conversion | 636,366 | not reported | not reported | Form 4 |
| 2019-05-28 | Glaxosmithkline plcDirector, 10% owner | Conversion | 893,195 | not reported | not reported | Form 4 |
| 2019-05-28 | Novartis Bioventures Ltd10% owner | Purchase | 168,630 | $14.00 | $2.4m | Form 4 |
| 2019-05-28 | Novartis Bioventures Ltd10% owner | Conversion | 636,366 | not reported | not reported | Form 4 |
| 2019-05-28 | Novartis Bioventures Ltd10% owner | Option exercise (in the money) | 71,450 | not reported | not reported | Form 4 |
| 2019-05-28 | Novartis Bioventures Ltd10% owner | Conversion | 893,195 | not reported | not reported | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 07:25 ET. Listed shows no prices and gives no investment advice.